Target- |
Mechanism- |
Active Org.- |
|
Active Indication- |
|
Drug Highest PhasePending |
First Approval Ctry. / Loc.- |
First Approval Date- |
[Translation] Single- and multiple-dose human pharmacokinetics of Tianhuning for injection
健康志愿者进行注射用天琥宁的单次及多次给药药代动力学试验,测定主要成分天琥宁的经时血药浓度,估算其药代动力学参数,确定在健康男性和女性志愿者单次及多次给药的药代动力学特征。
[Translation] Single- and multiple-dose pharmacokinetic tests of Tianhuning for injection were carried out in healthy volunteers, the menstrual blood concentration of the main ingredient Tianhuning was measured, and its pharmacokinetic parameters were estimated, and the pharmacokinetic parameters of Tianhuning in healthy men and women were determined. Pharmacokinetic profile of single and multiple doses in volunteers.
注射用天琥宁治疗急性上呼吸道感染的随机、单盲、阳性药/安慰剂平行对照、多中心Ⅱb期临床试验
[Translation] A randomized, single-blind, active drug/placebo parallel controlled, multicenter phase IIb clinical trial of Tianhuning for injection in the treatment of acute upper respiratory tract infection
以注射用穿琥宁/安慰剂为对照,评价注射用天琥宁治疗急性上呼吸道感染的有效性与安全性。
[Translation] Taking Chuanhuning for injection/placebo as a control, the efficacy and safety of Tianhuning for injection in the treatment of acute upper respiratory tract infection were evaluated.
100 Clinical Results associated with Sichuan Biaoxin Pharmaceutical Technology Co., Ltd.
0 Patents (Medical) associated with Sichuan Biaoxin Pharmaceutical Technology Co., Ltd.
100 Deals associated with Sichuan Biaoxin Pharmaceutical Technology Co., Ltd.
100 Translational Medicine associated with Sichuan Biaoxin Pharmaceutical Technology Co., Ltd.